Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
FLOT
Description:
A label associated with bacterial flotillin proteins, which organize membrane microdomains; its exact expansion or intended meaning is unclear.
Primary topic:
Gastric Cancer Management and Outcomes (45%)
Related topics:
Gastric Cancer Management and Outcomes (45%),
Esophageal Cancer Research and Treatment (11%),
Colorectal Cancer Treatments and Studies (9%)
OpenAlex ID:
keywords/flot
Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer: The AIO-FLOT3 Trial
2017
·
Salah-Eddin Al-Batran
, Nils Homann
, et al.
·
JAMA Oncology
·
519
PDF
Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial
2011
·
Richard A Adams
, Angela M Meade
, et al.
·
The Lancet Oncology
·
288
Perioperative chemotherapy with docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) for resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma (FLOT4-AIO): A multicenter, randomized phase 3 trial.
2017
·
Salah-Eddin Al-Batran
, Nils Homann
, et al.
·
Journal of Clinical Oncology
·
271
Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial
2023
·
Sylvie Lorenzen
, Thorsten Oliver Götze
, et al.
·
Journal of Clinical Oncology
·
256
EORTC-1203-GITCG - the “INNOVATION”-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group
2019
·
Anna Dorothea Wagner
, Heike I. Grabsch
, et al.
·
BMC Cancer
·
125
PDF
Perioperative trastuzumab and pertuzumab in combination with FLOT versus FLOT alone for HER2-positive resectable esophagogastric adenocarcinoma: Final results of the PETRARCA multicenter randomized phase II trial of the AIO.
2020
·
Ralf Dieter Hofheinz
, Georg Martin Haag
, et al.
·
Journal of Clinical Oncology
·
97
The biofilm formation defect of a B acillus subtilis flotillin‐defective mutant involves the protease FtsH
2012
·
Ana Yepes
, Johannes Schneider
, et al.
·
Molecular Microbiology
·
87
Perioperative platin-based chemotherapy for locally advanced esophagogastric adenocarcinoma: Postoperative chemotherapy has a substantial impact on outcome
2015
·
T. Glatz
, P. Bronsert
, et al.
·
European Journal of Surgical Oncology
·
59
Synthetic Motility and Cell Shape Defects Associated with Deletions of Flotillin/Reggie Paralogs in Bacillus subtilis and Interplay of These Proteins with NfeD Proteins
2012
·
F. Dempwolff
, H. M. Moller
, et al.
·
Journal of Bacteriology
·
54
PDF
Super Resolution Fluorescence Microscopy and Tracking of Bacterial Flotillin (Reggie) Paralogs Provide Evidence for Defined-Sized Protein Microdomains within the Bacterial Membrane but Absence of Clusters Containing Detergent-Resistant Proteins
2016
·
Felix Dempwolff
, Felix K. Schmidt
, et al.
·
PLoS Genetics
·
53
PDF
Spatio-temporal Remodeling of Functional Membrane Microdomains Organizes the Signaling Networks of a Bacterium
2015
·
Johannes Schneider
, Teresa Klein
, et al.
·
PLoS Genetics
·
50
PDF
Gastric cancer with positive peritoneal cytology: survival benefit after induction chemotherapy and conversion to negative peritoneal cytology
2021
·
Massimiliano Valletti
, Dilmurodjon Eshmuminov
, et al.
·
World Journal of Surgical Oncology
·
48
PDF
Pathological complete response (pCR) to 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) with or without durvalumab (D) in resectable gastric and gastroesophageal junction cancer (GC/GEJC): Subgroup analysis by region from the phase 3, randomized, double-blind MATTERHORN study.
2024
·
Yelena Y. Janjigian
, Salah-Eddin Al-Batran
, et al.
·
Journal of Clinical Oncology
·
39
PDF
Perioperative ramucirumab in combination with FLOT versus FLOT alone for resectable esophagogastric adenocarcinoma (RAMSES/FLOT7): Results of the phase II-portion—A multicenter, randomized phase II/III trial of the German AIO and Italian GOIM.
2020
·
Salah-Eddin Al-Batran
, Ralf Dieter Hofheinz
, et al.
·
Journal of Clinical Oncology
·
39
The deletion of bacterial dynamin and flotillin genes results in pleiotrophic effects on cell division, cell growth and in cell shape maintenance
2012
·
Felix Dempwolff
, Hanna M Wischhusen
, et al.
·
BMC Microbiology
·
39
PDF
Predictive value of chemotherapy-related high-density lipoprotein cholesterol (HDL) elevation in patients with colorectal cancer receiving adjuvant chemotherapy: an exploratory analysis of 851 cases
2016
·
Yun Wang
, Zhi-qiang Wang
, et al.
·
Oncotarget
·
38
PDF
In vivo characterization of the scaffold activity of flotillin on the membrane kinase KinC of Bacillus subtilis
2015
·
Johannes Schneider
, Benjamin Mielich-Süss
, et al.
·
Microbiology
·
37
Immune profile and immunosurveillance in treatment-naive and neoadjuvantly treated esophageal adenocarcinoma
2020
·
Svenja Wagener-Ryczek
, Max Schoemmel
, et al.
·
Cancer Immunology Immunotherapy
·
35
PDF
Docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) as perioperative treatment of resectable gastric or gastro-esophageal junction adenocarcinoma: The multicenter, randomized phase 3 FLOT4 trial (German Gastric Group at AIO)
2017
·
Salah-Eddin Al-Batran
, Claudia Pauligk
, et al.
·
Annals of Oncology
·
34
The CAIX inhibitor SLC-0111 exerts anti-cancer activity on gastric cancer cell lines and resensitizes resistant cells to 5-Fluorouracil, taxane-derived, and platinum-based drugs
2023
·
Elena Andreucci
, Alessio Biagioni
, et al.
·
Cancer Letters
·
31
PDF
Tumor Regression Grade and Overall Survival following Gastrectomy with Preoperative Therapy for Gastric Cancer
2023
·
Andrew J. Sinnamon
, Michelle Savoldy
, et al.
·
Annals of Surgical Oncology
·
31
Phase II study of perioperative toripalimab in combination with FLOT in patients with locally advanced resectable gastric/gastroesophageal junction (GEJ) adenocarcinoma.
2021
·
Hongli Li
, Jingyu Deng
, et al.
·
Journal of Clinical Oncology
·
30
Comparative Effectiveness of Neoadjuvant Treatments for Resectable Gastroesophageal Cancer: A Network Meta-Analysis
2018
·
Zhaolun Cai
, Yiqiong Yin
, et al.
·
Frontiers in Pharmacology
·
29
PDF
Perioperative chemotherapy with docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) for resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma (FLOT4-AIO): A multicenter, randomized phase 3 trial
2017
·
T Götze
, N Homann
, et al.
·
Zeitschrift für Gastroenterologie
·
26
Heterogeneous localisation of membrane proteins in Staphylococcus aureus
2018
·
Felix Weihs
, Katarzyna Wacnik
, et al.
·
Scientific Reports
·
24
PDF
Show more works
View as search
Works count:
292
Citation count:
2,887
Year
Topic
Type